Solventum SOLV Stock options excluded as their inclusion would be anti-dilutive (in shares)

Stock options excluded as their inclusion would be anti-dilutive (in shares) at other companies

3MMMM

7.1M-51.4%

UnitedHealth GroupUNH

18M+200%

Baxter InternationalBAX

25M+25.0%

GE HealthCare TechnologiesGEHC

——

Medline, Inc. MDLN

——

AbbottABT

——

Other financials

Income statement

See full

Revenue$2.0B-3.0%

Gross profit$1.1B-1.5%

Operating income$81.0M-46.7%

Net income$13.0M-90.5%

EPS (diluted)$0.07-91.0%

Balance sheet

See full

Cash & equivalents$561.0M+5.1%

Total debt$5.8B-26.8%

Total equity$5.0B+52.3%

Total assets$14.1B-3.0%

Cash flow

See full

Operating cash flow-$189.0M-752%

CapEx$84.0M-22.9%

Free cash flow-$273.0M-241%

Valuation

See full

Market cap$13.06B-13.9%

Enterprise value$18.29B-19.4%

P/E9.1×-30.9×

P/S1.6×-0.2×

Profitability

See full

Gross margin53.7%-0.9pp

Operating margin25.5%+15.8pp

Net margin17.3%+12.8pp

FCF margin4.6%-13.9pp

Returns & leverage

See full

Return on equity34.8%+24.1pp

Debt / equity1.2×-1.3×

Current ratio1.1×-0.1×

Where this comes from

Reported directly by Solventum in its filing.

Tagged under the XBRL concept us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount.

The official record: Solventum’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Solventum's stock options excluded as their inclusion would be anti-dilutive (in shares).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Solventum's stock options excluded as their inclusion would be anti-dilutive (in shares)?: Solventum (SOLV) reported stock options excluded as their inclusion would be anti-dilutive (in shares) of 3.6M in Q1 2026.
How has Solventum's stock options excluded as their inclusion would be anti-dilutive (in shares) changed year-over-year?: Solventum's stock options excluded as their inclusion would be anti-dilutive (in shares) decreased by 12.2% year-over-year, from 4.1M to 3.6M.